Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
6.09
+0.07 (1.16%)
At close: May 8, 2026, 4:00 PM EDT
6.21
+0.12 (1.97%)
After-hours: May 8, 2026, 4:50 PM EDT
Cadrenal Therapeutics Market Cap
Cadrenal Therapeutics has a market cap or net worth of $18.75 million as of May 8, 2026. Its market cap has decreased by -43.16% in one year.
Market Cap
18.75M
Enterprise Value
16.44M
1-Year Change
-43.16%
Ranking
Category
Stock Price
$6.09
Market Cap Chart
Since the IPO on January 20, 2023, Cadrenal Therapeutics's market cap has decreased from $58.17M to $18.75M, a decrease of -67.77%. That is a compound annual growth rate of -29.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 18.75M | 18.26% |
| Dec 31, 2025 | 15.85M | -38.62% |
| Dec 31, 2024 | 25.83M | 168.05% |
| Dec 29, 2023 | 9.64M | -83.44% |
| Jan 20, 2023 | 58.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Exicure | 21.61M |
| Pasithea Therapeutics | 21.20M |
| Quince Therapeutics | 19.89M |
| Lipocine | 19.50M |
| SeaStar Medical Holding | 19.45M |
| Cocrystal Pharma | 19.44M |
| OSR Holdings | 19.34M |
| Citius Pharmaceuticals | 18.06M |